Pathstone Holdings LLC Raises Holdings in Surgery Partners, Inc. (NASDAQ:SGRY)

Pathstone Holdings LLC increased its position in Surgery Partners, Inc. (NASDAQ:SGRY) by 30.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 57,347 shares of the company’s stock after buying an additional 13,534 shares during the quarter. Pathstone Holdings LLC’s holdings in Surgery Partners were worth $1,849,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in the company. Vanguard Group Inc. raised its position in Surgery Partners by 0.8% in the first quarter. Vanguard Group Inc. now owns 7,479,009 shares of the company’s stock valued at $223,099,000 after purchasing an additional 61,400 shares during the period. DekaBank Deutsche Girozentrale raised its position in Surgery Partners by 102.0% in the first quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock valued at $80,000 after purchasing an additional 1,375 shares during the period. Wesbanco Bank Inc. raised its position in Surgery Partners by 53.4% in the second quarter. Wesbanco Bank Inc. now owns 39,363 shares of the company’s stock valued at $936,000 after purchasing an additional 13,700 shares during the period. SG Americas Securities LLC raised its position in Surgery Partners by 190.0% in the second quarter. SG Americas Securities LLC now owns 17,276 shares of the company’s stock valued at $411,000 after purchasing an additional 11,318 shares during the period. Finally, Raymond James & Associates raised its position in Surgery Partners by 6.8% in the second quarter. Raymond James & Associates now owns 68,872 shares of the company’s stock valued at $1,638,000 after purchasing an additional 4,370 shares during the period.

Surgery Partners Stock Up 2.3 %

NASDAQ:SGRY opened at $23.41 on Thursday. The company has a market capitalization of $2.98 billion, a price-to-earnings ratio of -47.69, a price-to-earnings-growth ratio of 19.47 and a beta of 2.76. Surgery Partners, Inc. has a one year low of $21.36 and a one year high of $36.92. The stock has a 50-day simple moving average of $29.52 and a 200 day simple moving average of $28.31. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings results on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). The firm had revenue of $770.40 million during the quarter, compared to analyst estimates of $768.99 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The firm’s revenue for the quarter was up 14.3% on a year-over-year basis. During the same quarter last year, the business posted $0.15 earnings per share. Sell-side analysts predict that Surgery Partners, Inc. will post 0.73 EPS for the current fiscal year.

Wall Street Analyst Weigh In

SGRY has been the topic of a number of analyst reports. Benchmark reaffirmed a “buy” rating and set a $50.00 target price on shares of Surgery Partners in a research report on Monday, August 26th. StockNews.com lowered Surgery Partners from a “hold” rating to a “sell” rating in a research report on Wednesday, August 7th. KeyCorp initiated coverage on Surgery Partners in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. Macquarie reaffirmed an “outperform” rating and set a $34.00 target price on shares of Surgery Partners in a research report on Tuesday, November 19th. Finally, UBS Group initiated coverage on Surgery Partners in a research report on Monday, October 14th. They set a “buy” rating and a $38.00 target price on the stock. One analyst has rated the stock with a sell rating, two have issued a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, Surgery Partners has an average rating of “Moderate Buy” and a consensus target price of $38.71.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.